MedPath

Evaluation of the efficacy of sofosbuvir/velpatasvir and ribavirin in Japanese hepatitis C patients who failed direct-acting antiviral agents: a prospective study in real life settings.

Not Applicable
Recruiting
Conditions
cirrhotic and non cirrhotic patients with hepatitis C virus
Registration Number
JPRN-UMIN000035713
Lead Sponsor
Toranomon Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
150
Inclusion Criteria

Not provided

Exclusion Criteria

decompensated cirrhosis severe anemia

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath